SARS-CoV-2 Antigen Rapid Qualitative Test Type A

SARS-CoV-2 Antigen Rapid Qualitative Test Type B

CRP Rapid Quantitative Test

The C-reactive protein(CRP) is synthesized by the liver in response to interleukin-6 and is well known as one of the classical acute-phase reactants. It is used as a marker of inflammation and cardiovascular diseases(C-VD). Biotime CRP test includes hs-CRP and normal CRP test parameters which has wider test range.

h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay)

h-FABP Rapid Quantitative Test (Chemiluminescence Immunoassay) is used for in vitro quantitative detection of the heart-type fatty acid binding protein (h-FABP) concentration in human serum, plasma that contains heparin /EDTA and other anticoagulants and venous whole blood samples, mainly used for auxiliary diagnosis of cardiac diseases.

AFP Rapid Quantitative Test

Alpha-fetoprotein (AFP) is a protein produced primarily by the liver in a developing baby (fetus) and the portion of a developing embryo that is similar to the yolk cavity in bird eggs (yolk sac tissues). AFP levels are typically elevated when a baby is born and then decline rapidly.

Dengue NS1 Antigen Rapid Qualitative Test (Fluorescence Immunoassay)

The Biotime Dengue NS1 Antigen Rapid Test is intended to qualitatively detect the dengue NS1 antigen in human serum, plasma, or whole blood samples on the Biotime FIA Analyzer by fluorescent immunoassay. The test is used asthe earlyaid diagnosis and screening of dengue virus infection. For in vitro diagnostic use only. For professional use only.

SARS-CoV-2 IgG/IgM Rapid Qualitative Test

The Biotime SARS-CoV-2 IgG/IgM Rapid Qualitative Test is intended to qualify the SARS-CoV-2 IgG and IgM antibody in human plasma, serum or whole blood by colloidal gold immunochromatography assay. The test can be used as an aid detection to SARS-CoV-2 infection and thus caused COVID-19 disease.

CEA Rapid Quantitative Test

Carcinoembryonic antigen (CEA) is a protein normally found in very low levels in the blood of adults. The CEA blood level may be increased in certain types of cancer and non-cancerous (benign) conditions. A CEA test is most commonly used for colorectal cancer.

HSV-1 IgG/IgM Rapid Test (Fluorescence Immunoassay)

The HSV-1 IgG/IgM Rapid Test is an in vitro immunoassay for the in vitro qualitative determination of IgG and IgM class antibodies to HSV1 in human serum. The test is intended for use as an aid in the assessment of immune status and as an aid in the diagnosis of HSV infection. HSV-1 IgM test shall not be used for prenatal screening of asymptomatic people, and the test results of this reagent shall not be used alone as the basis for termination of pregnancy. -Fluorescent immunoassay -Herpes simplex viruses 1 (HSV-1) infection -For in vitro diagnostic use only. For professional use only.

Solutions

Covid-19 Solution

SARS-CoV-2 Antigen Rapid Test

SARS-CoV-2 Antigen Rapid Qualitative Test Type A